Insulin is a generic prescription drug approved for blood sugar management in certain animals, including cats. Learn how to save money on your cat's prescription.

The designation supports priority engagement with the FDA as Portal Diabetes advances clinical trials and regulatory submissions.

Scientists succeed in creating an artificial pancreas that regulates glucose, opening the door to treating diabetes without injections.

Portal Diabetes announced today that it received FDA breakthrough device designation for its implantable insulin pump system.

A groundbreaking new study offers hope that people with diabetes may no longer need to take insulin injections every day. The research, published in Science Translational Medicine, was led by ...

Waseem is a writer here at GameRant. He can still feel the pain of Harry Du Bois in Disco Elysium, the confusion of Alan Wake in the Remedy Connected Universe, the force of Ken's shoryukens and the ...

A pioneering study marks a major step toward eliminating the need for daily insulin injections for people with diabetes. The study was led by Assistant Professor Shady Farah of the Faculty of Chemical ...

Could a Living Implant End Daily Insulin Injections? Groundbreaking research reveals a self-regulating, implantable living technology that could offer hope for millions with diabetes and other chronic ...

Abstract: A phase-shifterless phase control method of magnetron arrays is proposed and experimentally demonstrated. By injecting a frequency-tunable signal into one magnetron within the mutual ...

A group that organized two nationwide "No Kings" protests last year is planning its next large-scale national demonstration on March 28, with a particular focus on Minnesota, which has emerged as ...

The updated labeling provides a new conversion chart for starting dosages when switching patients from subcutaneous mealtime insulin to Afrezza. The Food and Administration (FDA) has approved updated ...

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a biopharmaceutical company dedicated to transforming chronic disease care through ...